(3R,4R)-2,5-Dioxotetrahydrofuran-3,4-diyl diacetate, 95.0%, 100g

N1-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide, 95.0%, 250mg

7-Chloro-5-nitro-1H-indazol-3-amine, 95.0%, 1g

Methyl 3-chloro-1H-indazole-5-carboxylate, 98%, 100mg

2-(3-Bromo-phenyl)-1H-imidazole, 95.0%, 1g

N-(2-Methoxy-5-methylphenyl)-4-methylbenzenesulfonamide, 95%, 2g

Long working distance plan phase contrast Fluarex 40x/0.65 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate, 95.0%, 5g

3-Bromo-6-(trifluoromethyl)-1H-indazole, 95.0%, 1g

methyl 3-formylpyrrolo[2,1-b][1,3]benzothiazole-1-carboxylate, 95.0%, 5g

3-Nitro-p-anisaldehyde>98.0%(GC)5g

5-(4-cyclohexylphenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 2g

(S)-octahydropyrazino[2,1-c][1,4]oxazine, 98%, 100mg